Revenue: The sum of all revenue fields included for a company's operating activities.
Oasmia Pharmaceutical AB (OASMY) had Revenue of $0.10M for the most recently reported fiscal year, ending 2022-12-31.
| Income Statement Financials | |
|
Revenue |
$0.10M |
$-35.35M |
|
$0.14M |
|
$-0.04M |
|
$36.18M |
|
$-36.08M |
|
$-0.17M |
|
$-35.35M |
|
$-35.35M |
|
$-35.35M |
|
$-35.35M |
|
$-35.35M |
|
$-35.35M |
|
$-36.08M |
|
$-11.07M |
|
164.40M |
|
164.40M |
|
$-0.21 |
|
$-0.21 |
|
| Balance Sheet Financials | |
$14.90M |
|
$1.28M |
|
$20.37M |
|
$35.27M |
|
$2.50M |
|
$0.51M |
|
$0.51M |
|
$3.02M |
|
$32.25M |
|
$28.89M |
|
$32.25M |
|
179.35M |
|
| Cash Flow Statement Financials | |
$-8.50M |
|
$-4.49M |
|
$13.30M |
|
$0.78M |
|
$0.94M |
|
$0.16M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.95 |
|
-- |
|
-- |
|
0.02 |
|
0.03 |
|
-40.39% |
|
-35866.90% |
|
-35866.90% |
|
-11010.35% |
|
-35144.73% |
|
-35144.73% |
|
$-8.53M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
0.28 |
|
1289.91 |
|
-109.62% |
|
-122.36% |
|
-100.24% |
|
-107.90% |
|
$0.18 |
|
$-0.05 |
|
$-0.05 |
|